Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 17, 2021 09:15 ET | Source: Biosplice Therapeutics, Inc.

First Subject Dosed in Biosplice Therapeutics Phase 1b Clinical Trial in Oncology

SAN DIEGO, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK kinase modulation for major...
June 21, 2021 09:15 ET | Source: Biosplice Therapeutics, Inc.

Dave Johnson Joins Biosplice Therapeutics Board of Directors

SAN DIEGO, June 21, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for...
April 20, 2021 08:45 ET | Source: Biosplice Therapeutics, Inc.

Biotech Veterans Troy Cox, Susannah Gray and Karen McGinnis Join Biosplice Therapeutics Board of Directors

SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for...
April 15, 2021 10:55 ET | Source: Biosplice Therapeutics, Inc.

Biosplice Therapeutics Closes $120 Million in Equity Financing to Advance Its Alternative Splicing Platform

New investors include Eventide, aMoon, SymBiosis II, Sands Capital and VeritionProceeds to support Biosplice’s clinical development of lorecivivint, its Phase 3 Osteoarthritis therapy, as well as its...